Effect of protein kinase C delta (PKC-δ) inhibition on the transcriptome of normal and systemic sclerosis human dermal fibroblasts in vitro

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Wermuth, Peter J ^a   Addya, Sankar ^b   Jimenez, Sergio A ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C DELTA; ROTTLERIN; SCLEROPROTEIN; SMALL INTERFERING RNA; TRANSCRIPTOME; ACETOPHENONE DERIVATIVE; BENZOPYRAN DERIVATIVE; ENZYME INHIBITOR;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MICROARRAY; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS; UPREGULATION; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; FIBROBLAST; METABOLISM; PATHOLOGY; SKIN;

ACETOPHENONES; BENZOPYRANS; CELLS, CULTURED; ENZYME INHIBITORS; FIBROBLASTS; HUMANS; PROTEIN KINASE C-DELTA; SCLERODERMA, SYSTEMIC; SKIN;

EID: 80855156781     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027110     Document Type: Article

References (54)

1. Kikkawa U, Ogita K, Ono Y, Asaoka Y, Shearman MS, et al. (1987) The common structure and activities of four subspecies of rat brain protein kinase C family. 1987. FEBS Lett 223: 212-216.
2. Carpenter D, Jackson T, Hanley MR, (1987) Protein kinase Cs. Coping with a growing family. Nature 325: 107-108.
3. Jaken S, Parker PJ, (2000) Protein kinase C binding partners. Bioessays 222: 245-254.
4. Spitaler M, Cantrell DA, (2004) Protein kinase C and beyond. Nat Immunol 5: 785-790.
5. Poole AW, Pula G, Hers I, Crosby D, Jones ML, (2004) PKC-interacting proteins: from function to pharmacy. Trends Pharmacol Sci 25: 528-535.
6. Newton AC, (2003) The ins and outs of protein kinase C. Methods Mol Biol 233: 3-7.
7. Newton AC, (2010) Protein kinase C: poised to signal. Am J Physiol Endocrinol Metab 298: E395-403 Epub 2009 Nov 24.
8. Jackson DN, Foster DA, (2004) The enigmatic protein kinase C delta: complex roles in cell proliferation and survival. FASEB J 18: 627-636.
9. Steinberg SF, (2004) Distinctive activation mechanisms and functions for protein kinase C delta. Biochem J 384: 449-459.
10. Vallee S, Laforest S, Fouchier F, Montero MP, Penel C, et al. (2004) Cytokine- induced upregulation of NF-kappaB, IL-8, and ICAM-1 is dependent on colonic cell polarity: implication for PKCdelta. Exp Cell Res 297: 165-185.
11. Wang Q, Wang X, Evers BM, (2003) Induction of cIAP-2 in human colon cancer cells through PKCδ/NF-κB. J Biol Chem 278: 51091-51099.
12. Page K, Li J, Zhou L, Iasvovskaia S, Corbit KC, et al. (2003) Regulation of airway epithelial cell NF-κB-dependent gene expression by protein kinase C-δ. J Immunol 170: 5681-5689.
13. Jimenez SA, Gaidarova S, Saitta B, Sandorfi N, Herrich DJ, et al. (2001) Role of protein kinase C-delta in the regulation of collagen gene expression in scleroderma fibroblasts. J Clin Invest 108: 1395-1403.
14. Gore-Hyer E, Pannu J, Smith EA, Grotendorst G, Trojanowska M, (2003) Selective stimulation of collagen synthesis in the presence of costimulatory insulin signaling by connective tissue growth factor in scleroderma fibroblasts. Arthritis Rheum 48: 798-806.
15. Zohlman A, Kamiya K, Kato K, Salvarezza SB, Doty SB, et al. (2008) Protein kinase C delta is necessary for the secretion of collagen type I from vascular smooth muscle cells. FASEB J 22: lb609.
16. Runyan CE, Schnaper HW, Poncelet AC, (2004) Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells. Am J Physiol Renal Physiol 285: F413-F422.
17. Ryer EJ, Hom RP, Sakakibara K, Nakayama KI, Nakayama K, et al. (2006) PKCdelta is necessary for Smad3 expression and transforming growth factor beta-induced fibronectin synthesis in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 26: 780-786 Epub 2006 Feb 9.
18. Runyan CE, Schnaper HW, Poncelet AC, (2003) Smad3 and PKCdelta mediate TGF-beta1-induced collagen I expression in human mesangial cells. Am J Physiol Renal Physiol 285: F413-22 Epub 2003 May 20.
19. Gschwendt M, Müller HJ, Kielbassa K, Zang R, Kittstein W, et al. (1994) Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93-98.
20. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, et al. (1988) Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol 15: 202-205.
21. Mi Z, Mai J, Lu X, Robbins PD, (2000) Characterization of a class of cationic peptides able to facilitate efficient protein transduction in vitro and in vivo. Mol Ther 2: 339-347.
22. Chen L, Hahn H, Wu G, Chen CH, Liron T, et al. (2001) Opposing cardioprotective actions and parallel hypertrophic effects of delta PC and epsilon PKC. Proc Natl Acad Sci U S A 98: 11114-11119.
23. Vadigepalli R, Chakravarthula P, Zak DE, Schwaber JS, Gonye GE, (2003) PAINT: a promoter analysis and interaction network generation tool for gene regulatory network identification. OMICS 7: 235-252.
24. Gonye GE, Chakravarthula P, Schwaber JS, Vadigepalli R, (2007) From Promoter Analysis to Transcriptional Regulatory Network Prediction Using PAINT. Gene Function Analysis, Methods in Molecular Biology, edited by Michael Ochs 408 Totowa Humana Press: 49-68.
25. Soltoff SP, (2007) Rottlerin: an inappropriate and ineffective inhibitor of PKCdelta. Trends Pharmacol Sci 28: 453-458 Epub 2007 Aug 10.
26. Mochly-Rosen D, Gordon AS, (1998) Anchoring proteins for protein kinase C: a means for isozyme selectivity. FASEB J 12: 35-42.
27. Modaressi S, Brechtel K, Christ B, Jungermann K, (1998) Human mitochondrial phosphoenolpyruvate carboxykinase 2 gene. Structure, chromosomal localization and tissue-specific expression. Biochem J 333: 359-366.
28. Stover PJ, Chen LH, Suh JR, Stover DM, Keyomarsi K, Shane B, (1997) Molecular cloning, characterization, and regulation of the human mitochondrial serine hydroxymethyltransferase gene. J Biol Chem 272: 1842-1848.
29. Wang N, Maurizi MR, Emmert-Buck L, Gottesman MM, (1994) Synthesis, processing, and localization of human Lon protease. J Biol Chem 269: 29308-29313.
30. Ron D, Habener JF, (1992) CHOP, a novel developmentally regulated nuclear protein that dimerizes with transcription factors C/EBP and LAP and functions as a dominant-negative inhibitor of gene transcription. Genes Dev 6: 439-653.
31. Ellisen LW, Ramsayer KD, Johannessen CM, Yang A, Beppu H, et al. (2002) REDD1, a developmentally regulated transcriptional target of p63 and p53, links p63 to regulation of reactive oxygen species. Mol Cell 10: 995-1005.
32. Bootcov MR, Bauskin AR, Valenzuela SM, Moore AG, Bansal M, et al. (1997) MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc Natl Acad Sci U S A 94: 11514-11519.
33. Esmon NL, Carroll RC, Esmon CT, (1983) Thrombomodulin blocks the ability of thrombin to activate platelets. J Biol Chem 258: 12238-12242.
34. Kiss-Toth E, Bagstaff SM, Sung HY, Jozsa V, Dempsey C, et al. (2004) Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. J Biol Chem 279: 42703-42708 Epub 2004 Aug 6.
35. Pan D, Zhe X, Jakkaraju S, Taylor GA, Schuger L, (2002) P311 induces a TGF-beta1-independent, nonfibrogenic myofibroblast phenotype. J Clin Invest 110: 1349-1358.
36. Asselah T, Bieche I, Laurendeau I, Paradis V, Vidaud D, et al. (2005) Liver gene expression signature of mild fibrosis in patients with chronic hepatitis C. Gastroenterology 129: 2064-2075.
37. Strieter RM, Keeley EC, Hughes MA, Burdick MD, Mehrad B, (2009) The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol 86: 1111-1118.
38. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, et al. (2004) Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 114: 438-446.
39. Tourkina E, Bonner M, Oates J, Hofbauer A, Richard M, et al. (2011) Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptide. Fibrogenesis Tissue Repair 4: 15.
40. Schnoor M, Betanzos A, Weber DA, Parkos CA, (2009) Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis. Mucosal Immunol 2: 33-42 Epub 2008 Sep 17.
41. Bell DM, Leung KK, Wheatley SC, Ng LJ, Zhou S, et al. (1997) SOX9 directly regulates the type-II collagen gene. Nat Genet 16: 174-178.
42. Hanley KP, Oakley F, Sugden S, Wilson DI, Mann DA, et al. (2008) Ectopic SOX9 mediates extracellular matrix deposition characteristic of organ fibrosis. J Biol Chem 283: 14063-14071.
43. Eby MT, Jasmin A, Kumar A, Sharma K, Chaudhary PM, (2000) TAJ, a novel member of the tumor necrosis factor receptor family, activates the c-Jun N-terminal kinase pathway and mediates caspase-independent cell death. J Biol Chem 275: 15336-15342.
44. Tan FK, Hildebrand BA, Lester MS, Stivers DN, Pounds S, et al. (2005) Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease. Arthritis Rheum 52: 865-876.
45. Gardner H, Shearstone JR, Bandaru R, Crowell T, Lynes M, et al. (2006) Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts. Arthritis Rheum 54: 1961-1973.
46. Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, et al. (2008) Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One 3: e2696.
47. Fuzii HT, Yoshikawa GT, Junta CM, Sandrin-Garcia P, Fachin AL, et al. (2008) Affected and non-affected skin fibroblasts from systemic sclerosis patients share a gene expression profile deviated from the one observed in healthy individuals. Clin Exp Rheumatol 26: 866-874.
48. Zhang Y, Zhou ZH, Bugge TH, Wahl LM, (2007) Urokinase-type plasminogen activator stimulation of monocyte matrix metalloproteinase-1 production is mediated by plasmin-dependent signaling through annexin A2 and inhibited by inactive plasmin. J Immunol 179: 3297-3304.
49. Varga J, Diaz-Perez A, Rosenbloom J, Jimenez SA, (1987) PGE2 causes a coordinate decrease in the steady state levels of fibronectin and types I and III procollagen mRNAs in normal human dermal fibroblasts. Biochem Biophys Res Commun 147: 1282-1288.
50. Huang SK, Wettlaufer SH, Chung J, Peters-Golden M, (2008) Prostaglandin E2 inhibits specific lung fibroblast functions via selective actions of PKA and Epac-. Am J Respir Cell Mol Biol 39: 482-489 Epub 2008 Apr 17.
51. Fruchtman S, Simmons JG, Michaylira CZ, Miller ME, Greenhalgh CJ, et al. (2005) Suppressor of cytokine signaling-2 modulates the fibrogenic actions of GH and IGF-I in intestinal mesenchymal cells. Am J Physiol Gastrointest Liver Physiol 289: G342-50 Epub 2005 Apr 14.
52. Sellers A, Murphy G, (1981) Collagenolytic enzymes and their naturally occurring inhibitors. Int Rev Connect Tissue Res 9: 151-190.
53. Iwata Y, Yoshizaki A, Ogawa F, Komura K, Hara T, et al. (2009) Increased serum pentraxin 3 in patients with systemic sclerosis. J Rheumatol 36: 976-983 Epub 2009 Feb 27.
54. Luchetti MM, Sambo P, Majlingová P, Svegliati Baroni S, Peri G, et al. (2004) Scleroderma fibroblasts constitutively express the long pentraxin PTX3. Clin Exp Rheumatol 22 (3 Suppl 33): S66-72.